摘要

Type IV collagenase is an essential metallopeptidase in the development of tumor invasion and angiogenesis. A series of novel low molecular-weight 1,3,4-thiadiazole derivatives were designed and synthesized as antitumor agents. The structures were confirmed by IR, H-1-NMR, and MS. Some of the target compounds display excellent potency toward MMP-2 and MMP-9 with inhibition rate > 50% at 10 mu M, meanwhile the selectivity towards MMP-9 is higher than towards MMP-2, and could be used as lead compounds for exploring new type IV collagenase inhibitors in the future.

全文